2-arachidonoylglycerol: a novel inhibitor of andr... [Cancer Res. 2004] - PubMed

Save items

loading

Related citations in PubMed

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. [Endocrinology. 2000]
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V. Endocrinology. 2000 Jan; 141(1):118-26.
Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. [Int J Cancer. 2007]
Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism.
Endsley MP, Aggarwal N, Isbell MA, Wheelock CE, Hammock BD, Falck JR, Campbell WB, Nithipatikom K. Int J Cancer. 2007 Sep 1; 121(5):984-91.
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. [Biochem Biophys Res Commun. 2005]
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells.
Nithipatikom K, Endsley MP, Isbell MA, Wheelock CE, Hammock BD, Campbell WB. Biochem Biophys Res Commun. 2005 Jul 15; 332(4):1028-33.
Review Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. [Prog Lipid Res. 2006]
Review Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
Sugiura T, Kishimoto S, Oka S, Gokoh M. Prog Lipid Res. 2006 Sep; 45(5):405-46. Epub 2006 Apr 19.
Review Endocannabinoids: synthesis and degradation. [Rev Physiol Biochem Pharmacol....]
Review Endocannabinoids: synthesis and degradation.
Di Marzo V. Rev Physiol Biochem Pharmacol. 2008; 160:1-24.

See reviews... See all...

Cited by 11 PubMed Central articles

Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism. [PLoS One. 2011]
Increasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.
Hamtiaux L, Hansoulle L, Dauguet N, Muccioli GG, Gallez B, Lambert DM. PLoS One. 2011; 6(10):e26823. Epub 2011 Oct 27.
Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer. [PLoS One. 2010]
Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
Fowler CJ, Hammarsten P, Bergh A. PLoS One. 2010 Dec 23; 5(12):e15205. Epub 2010 Dec 23.
Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells. [Prostaglandins Other Lipid Med...]
Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.
Nithipatikom K, Isbell MA, Endsley MP, Woodliff JE, Campbell WB. Prostaglandins Other Lipid Mediat. 2011 Feb; 94(1-2):34-43. Epub 2010 Dec 15.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cance...
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.
Cancer Res. 2004 Dec 15 ;64(24):8826-30.

PubMed
Memories aren't made of this: amnesia at the movies.
Memories aren't made of this: amnesia at the movies.
BMJ. 2004 Dec 18 ;329(7480):1480-3.

PubMed
Easy ways to resist change in medicine.
Easy ways to resist change in medicine.
BMJ. 2004 Dec 18 ;329(7480):1473-4.

PubMed
Randomised controlled trial of intravenous antibiotic treatment for cellulitis a...
Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital.
BMJ. 2005 Jan 15 ;330(7483):129. Epub 2004 Dec 16 .

PubMed
A comparison of two computer-administered versions of the NIMH Diagnostic Interv...
A comparison of two computer-administered versions of the NIMH Diagnostic Interview Schedule.
J Psychiatr Res. 1992 Jan ;26(1):85-95.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 11 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information